265 related articles for article (PubMed ID: 11352660)
21. Expression and regulation of endothelial nitric oxide synthase by vascular endothelial growth factor in ECV 304 cells.
Park JS; Hong GR; Baek SW; Shin DG; Kim YJ; Shim BS
J Korean Med Sci; 2002 Apr; 17(2):161-7. PubMed ID: 11961297
[TBL] [Abstract][Full Text] [Related]
22. Effect of VEGF on retinal microvascular endothelial hydraulic conductivity: the role of NO.
Lakshminarayanan S; Antonetti DA; Gardner TW; Tarbell JM
Invest Ophthalmol Vis Sci; 2000 Dec; 41(13):4256-61. PubMed ID: 11095623
[TBL] [Abstract][Full Text] [Related]
23. Nitric oxide synthase inhibitors modulate nerve growth factor-mediated regulation of amyloid precursor protein expression in PC12 cells.
Binnington JC; Kalisch BE
J Neurochem; 2007 Apr; 101(2):422-33. PubMed ID: 17402971
[TBL] [Abstract][Full Text] [Related]
24. Essential role of calcium in vascular endothelial growth factor A-induced signaling: mechanism of the antiangiogenic effect of carboxyamidotriazole.
Faehling M; Kroll J; Föhr KJ; Fellbrich G; Mayr U; Trischler G; Waltenberger J
FASEB J; 2002 Nov; 16(13):1805-7. PubMed ID: 12354692
[TBL] [Abstract][Full Text] [Related]
25. Two distinct signalling pathways are involved in FGF2-stimulated proliferation of choriocapillary endothelial cells: a comparative study with VEGF.
Zubilewicz A; Hecquet C; Jeanny JC; Soubrane G; Courtois Y; Mascarelli F
Oncogene; 2001 Mar; 20(12):1403-13. PubMed ID: 11313884
[TBL] [Abstract][Full Text] [Related]
26. Induction of endothelial cell decay-accelerating factor by vascular endothelial growth factor: a mechanism for cytoprotection against complement-mediated injury during inflammatory angiogenesis.
Mason JC; Lidington EA; Yarwood H; Lublin DM; Haskard DO
Arthritis Rheum; 2001 Jan; 44(1):138-50. PubMed ID: 11212152
[TBL] [Abstract][Full Text] [Related]
27. Role for nitric oxide in the hyperpermeability and hemodynamic changes induced by intravenous VEGF.
Tilton RG; Chang KC; LeJeune WS; Stephan CC; Brock TA; Williamson JR
Invest Ophthalmol Vis Sci; 1999 Mar; 40(3):689-96. PubMed ID: 10067972
[TBL] [Abstract][Full Text] [Related]
28. Is galectin-1 a trigger for trophoblast cell fusion?: the MAP-kinase pathway and syncytium formation in trophoblast tumour cells BeWo.
Fischer I; Weber M; Kuhn C; Fitzgerald JS; Schulze S; Friese K; Walzel H; Markert UR; Jeschke U
Mol Hum Reprod; 2011 Dec; 17(12):747-57. PubMed ID: 21831883
[TBL] [Abstract][Full Text] [Related]
29. VEGF increases permeability of the endothelial cell monolayer by activation of PKB/akt, endothelial nitric-oxide synthase, and MAP kinase pathways.
Lal BK; Varma S; Pappas PJ; Hobson RW; Durán WN
Microvasc Res; 2001 Nov; 62(3):252-62. PubMed ID: 11678628
[TBL] [Abstract][Full Text] [Related]
30. VEGF-dependent signaling in retinal microvascular endothelial cells.
Enaida H; Kabuyama Y; Oshima Y; Sakamoto T; Kato K; Kochi H; Homma Y
Fukushima J Med Sci; 1999 Dec; 45(2):77-91. PubMed ID: 11039605
[TBL] [Abstract][Full Text] [Related]
31. Nitric oxide synthase II gene disruption: implications for tumor growth and vascular endothelial growth factor production.
Konopka TE; Barker JE; Bamford TL; Guida E; Anderson RL; Stewart AG
Cancer Res; 2001 Apr; 61(7):3182-7. PubMed ID: 11306506
[TBL] [Abstract][Full Text] [Related]
32. Activation of EphA receptor tyrosine kinase inhibits the Ras/MAPK pathway.
Miao H; Wei BR; Peehl DM; Li Q; Alexandrou T; Schelling JR; Rhim JS; Sedor JR; Burnett E; Wang B
Nat Cell Biol; 2001 May; 3(5):527-30. PubMed ID: 11331884
[TBL] [Abstract][Full Text] [Related]
33. Vascular endothelial growth factor governs endothelial nitric-oxide synthase expression via a KDR/Flk-1 receptor and a protein kinase C signaling pathway.
Shen BQ; Lee DY; Zioncheck TF
J Biol Chem; 1999 Nov; 274(46):33057-63. PubMed ID: 10551875
[TBL] [Abstract][Full Text] [Related]
34. Gene transfer of vascular endothelial growth factor and endothelial nitric oxide synthase--implications for gene therapy in cardiovascular diseases.
Dulak J; Józkowicz A; Guevara I; Dembińska-Kieć A
Pol J Pharmacol; 1999; 51(3):233-41. PubMed ID: 10600037
[TBL] [Abstract][Full Text] [Related]
35. Nitric oxide mediates ultrasound-induced hypoxia-inducible factor-1alpha activation and vascular endothelial growth factor-A expression in human osteoblasts.
Wang FS; Kuo YR; Wang CJ; Yang KD; Chang PR; Huang YT; Huang HC; Sun YC; Yang YJ; Chen YJ
Bone; 2004 Jul; 35(1):114-23. PubMed ID: 15207747
[TBL] [Abstract][Full Text] [Related]
36. Immediate and delayed VEGF-mediated NO synthesis in endothelial cells: role of PI3K, PKC and PLC pathways.
Gélinas DS; Bernatchez PN; Rollin S; Bazan NG; Sirois MG
Br J Pharmacol; 2002 Dec; 137(7):1021-30. PubMed ID: 12429574
[TBL] [Abstract][Full Text] [Related]
37. Vascular endothelial growth factor activates MAP kinase and enhances collagen synthesis in human mesangial cells.
Amemiya T; Sasamura H; Mifune M; Kitamura Y; Hirahashi J; Hayashi M; Saruta T
Kidney Int; 1999 Dec; 56(6):2055-63. PubMed ID: 10594781
[TBL] [Abstract][Full Text] [Related]
38. Nitric oxide is an upstream signal of vascular endothelial growth factor-induced extracellular signal-regulated kinase1/2 activation in postcapillary endothelium.
Parenti A; Morbidelli L; Cui XL; Douglas JG; Hood JD; Granger HJ; Ledda F; Ziche M
J Biol Chem; 1998 Feb; 273(7):4220-6. PubMed ID: 9461619
[TBL] [Abstract][Full Text] [Related]
39. Isolation and characterization of human thyroid endothelial cells.
Patel VA; Logan A; Watkinson JC; Uz-Zaman S; Sheppard MC; Ramsden JD; Eggo MC
Am J Physiol Endocrinol Metab; 2003 Jan; 284(1):E168-76. PubMed ID: 12388152
[TBL] [Abstract][Full Text] [Related]
40. Role of nitric oxide, prostaglandins and tyrosine kinase in vascular endothelial growth factor-induced increase in vascular permeability in mouse skin.
Fujii E; Irie K; Ohba K; Ogawa A; Yoshioka T; Yamakawa M; Muraki T
Naunyn Schmiedebergs Arch Pharmacol; 1997 Oct; 356(4):475-80. PubMed ID: 9349634
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
